US Stock MarketDetailed Quotes

OSTX OS Therapies

Watchlist
  • 4.000
  • 0.0000.00%
Close Jun 26 16:00 ET
82.39MMarket Cap-10928P/E (TTM)

OS Therapies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-39.87%630.23K
-2.33%4.34M
17.84%1.05M
-8.08%4.45M
889.39K
4.84M
Selling and administrative expenses
-8.78%268.42K
-2.87%1.12M
44.65%294.25K
-23.27%1.15M
--203.42K
--1.5M
-General and administrative expense
-8.78%268.42K
-2.87%1.12M
44.65%294.25K
-23.27%1.15M
--203.42K
--1.5M
Research and development costs
-52.00%361.81K
-2.26%3.22M
10.08%753.78K
51.39%3.29M
--684.76K
--2.17M
Other operating expenses
----
325.95%5.15K
----
-99.90%1.21K
--1.21K
--1.16M
Operating profit
39.87%-630.23K
2.33%-4.34M
-17.84%-1.05M
8.08%-4.45M
-889.39K
-4.84M
Net non-operating interest income expense
-3.73%-828.76K
-90.72%-3.45M
-68.86%-798.94K
29.99%-1.81M
-473.13K
-2.58M
Non-operating interest income
----
--2
----
--0
----
----
Non-operating interest expense
3.73%828.76K
90.72%3.45M
68.86%798.94K
-29.99%1.81M
--473.13K
--2.58M
Other net income (expense)
Income before tax
21.01%-1.46M
-24.57%-7.79M
-35.56%-1.85M
15.71%-6.25M
-1.36M
-7.42M
Income tax
Net income
21.01%-1.46M
-24.57%-7.79M
-35.56%-1.85M
15.71%-6.25M
-1.36M
-7.42M
Net income continuous Operations
21.01%-1.46M
-24.57%-7.79M
-35.56%-1.85M
15.71%-6.25M
---1.36M
---7.42M
Minority interest income
Net income attributable to the parent company
21.01%-1.46M
-24.57%-7.79M
-35.56%-1.85M
15.71%-6.25M
-1.36M
-7.42M
Preferred stock dividends
0.00%31.25K
0.00%125K
0.00%31.25K
33.33%125K
31.25K
93.75K
Other preferred stock dividends
Net income attributable to common stockholders
20.66%-1.49M
-24.09%-7.92M
-34.76%-1.88M
15.10%-6.38M
-1.39M
-7.51M
Basic earnings per share
20.66%-0.0724
-24.09%-0.3843
-52.17%-0.0912
4.78%-0.3097
-0.0599
-0.3253
Diluted earnings per share
20.66%-0.0724
-24.09%-0.3843
-52.17%-0.0912
4.78%-0.3097
-0.0599
-0.3253
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Total revenue 000000
Operating revenue --0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -39.87%630.23K-2.33%4.34M17.84%1.05M-8.08%4.45M889.39K4.84M
Selling and administrative expenses -8.78%268.42K-2.87%1.12M44.65%294.25K-23.27%1.15M--203.42K--1.5M
-General and administrative expense -8.78%268.42K-2.87%1.12M44.65%294.25K-23.27%1.15M--203.42K--1.5M
Research and development costs -52.00%361.81K-2.26%3.22M10.08%753.78K51.39%3.29M--684.76K--2.17M
Other operating expenses ----325.95%5.15K-----99.90%1.21K--1.21K--1.16M
Operating profit 39.87%-630.23K2.33%-4.34M-17.84%-1.05M8.08%-4.45M-889.39K-4.84M
Net non-operating interest income expense -3.73%-828.76K-90.72%-3.45M-68.86%-798.94K29.99%-1.81M-473.13K-2.58M
Non-operating interest income ------2------0--------
Non-operating interest expense 3.73%828.76K90.72%3.45M68.86%798.94K-29.99%1.81M--473.13K--2.58M
Other net income (expense)
Income before tax 21.01%-1.46M-24.57%-7.79M-35.56%-1.85M15.71%-6.25M-1.36M-7.42M
Income tax
Net income 21.01%-1.46M-24.57%-7.79M-35.56%-1.85M15.71%-6.25M-1.36M-7.42M
Net income continuous Operations 21.01%-1.46M-24.57%-7.79M-35.56%-1.85M15.71%-6.25M---1.36M---7.42M
Minority interest income
Net income attributable to the parent company 21.01%-1.46M-24.57%-7.79M-35.56%-1.85M15.71%-6.25M-1.36M-7.42M
Preferred stock dividends 0.00%31.25K0.00%125K0.00%31.25K33.33%125K31.25K93.75K
Other preferred stock dividends
Net income attributable to common stockholders 20.66%-1.49M-24.09%-7.92M-34.76%-1.88M15.10%-6.38M-1.39M-7.51M
Basic earnings per share 20.66%-0.0724-24.09%-0.3843-52.17%-0.09124.78%-0.3097-0.0599-0.3253
Diluted earnings per share 20.66%-0.0724-24.09%-0.3843-52.17%-0.09124.78%-0.3097-0.0599-0.3253
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg